Top 10 Companies in the United States Oligonucleotide Market (2026): Market Leaders Powering Biotech Innovation

Global Oligonucleotide Market in the United States is poised for explosive growth, driven by breakthroughs in gene therapy, expanding diagnostics, and vaccine development.

United States Oligonucleotide Market – View in Detailed Research Report

The United States Oligonucleotide market size was valued at USD 1.23 billion in 2024 and is projected to reach USD 2.56 billion by 2030, at a CAGR of 13.0% during the forecast period 2024-2030.

Oligonucleotides are short DNA or RNA molecules used in genetic testing, research, and as therapeutic agents, playing a crucial role in personalized medicine and biotechnology. The US Oligonucleotide market is experiencing rapid growth, driven by advancements in gene therapy, increasing adoption in molecular diagnostics, and expanding applications in drug discovery. In 2023, total production reached 15,000 kg, with the pharmaceutical and biotechnology sector accounting for 65% of market value. The market saw a 30% increase in demand for therapeutic oligonucleotides in 2023, particularly for rare genetic disorders. Use in PCR and molecular diagnostics is growing at 18% annually. The market is witnessing a trend towards modified oligonucleotides with improved stability and efficacy, with a 35% year-over-year increase in R&D investments for novel chemical modifications. Adoption in CRISPR-based gene editing applications grew by 40% in 2023. Leading manufacturers are focusing on scaling up production and reducing costs, with a 45% increase in investments in automated synthesis and purification technologies. The industry is also seeing increased interest in oligonucleotide-based vaccines, with a 50% rise in research projects exploring mRNA and DNA vaccine platforms.

The forecast timeline includes base year 2025, estimated year 2026, and forecast year 2034.

🔟 1. Integrated DNA Technologies

Headquarters: Newark, New Jersey, USA
Key Offering: Custom oligonucleotide synthesis, high-throughput screening, gene editing tools

Integrated DNA Technologies (IDT) is a leading provider of custom oligonucleotides for research, diagnostics, and therapeutics. Their extensive library of modified bases and automated synthesis platforms enable rapid development of diagnostic assays and gene editing reagents.

Sustainability & Growth Initiatives:

• Investment in green chemistry for synthesis processes
• Partnerships with academic institutions for rare disease research
• Expansion of automated purification lines to reduce waste

---

9️⃣ 2. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: Analytical instruments, oligonucleotide synthesis, diagnostic kits

Agilent Technologies supplies high-quality oligonucleotides for genomics, proteomics, and pharmaceutical research. Their integrated solutions combine synthesis, purification, and quality control to accelerate drug discovery pipelines.

Sustainability & Growth Initiatives:

• Development of low-energy synthesis protocols
• Collaboration with biotech firms for CRISPR reagent production
• Investment in digital supply chain tracking

---

8️⃣ 3. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Custom oligonucleotides, PCR kits, next‑generation sequencing reagents

Thermo Fisher Scientific is a global leader in life‑science solutions, offering a comprehensive portfolio of oligonucleotides for diagnostics, research, and therapeutics. Their advanced synthesis platforms support high‑throughput production and stringent quality standards.

Sustainability & Growth Initiatives:

• Scaling up automated synthesis to improve yield and reduce solvent usage
• Partnerships for mRNA vaccine development
• Investment in renewable energy for manufacturing facilities

---

7️⃣ 4. Eurofins Genomics

Headquarters: Luxembourg, Luxembourg (US operations in Boston, MA)
Key Offering: Genomic testing kits, custom oligonucleotide panels, sequencing services

Eurofins Genomics provides high‑quality oligonucleotides for clinical diagnostics and research. Their portfolio includes gene panels for rare disease diagnostics and personalized medicine applications.

Sustainability & Growth Initiatives:

• Adoption of eco‑friendly purification methods
• Expansion of rare disease testing capabilities
• Collaboration with pharma for therapeutic oligo development

---

6️⃣ 5. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Diagnostic imaging reagents, oligonucleotide‑based assays, molecular diagnostics

GE Healthcare delivers oligonucleotide‑based diagnostics for oncology and infectious disease testing. Their integrated platforms combine synthesis, purification, and assay development to support clinical workflows.

Sustainability & Growth Initiatives:

• Investments in low‑toxicity reagents
• Partnerships with hospitals for diagnostic assay validation
• Digital health integration for data analytics

---

5️⃣ 6. Bio‑Synthesis Inc.

Headquarters: Huntsville, Alabama, USA
Key Offering: Custom oligonucleotides, gene synthesis, vaccine platform development

Bio‑Synthesis Inc. specializes in custom oligo synthesis for vaccine research and gene therapy. Their state‑of‑the‑art facilities support rapid scale‑up for clinical trials.

Sustainability & Growth Initiatives:

• Automation of synthesis to improve reproducibility
• Partnerships with mRNA vaccine developers
• Implementation of circular waste management

---

4️⃣ 7. LGC Biosearch Technologies

Headquarters: Hitchin, United Kingdom (US office in New York, NY)
Key Offering: Oligonucleotide synthesis, gene editing reagents, custom kits

LGC Biosearch Technologies offers high‑purity oligonucleotides for CRISPR, diagnostics, and research. Their automated platforms enable rapid turnaround and high throughput.

Sustainability & Growth Initiatives:

• Green chemistry initiatives for synthesis
• Collaboration with biotech for rare disease therapeutics
• Investment in renewable energy for labs

---

3️⃣ 8. TriLink BioTechnologies

Headquarters: Fremont, California, USA
Key Offering: CRISPR reagents, synthetic biology kits, oligonucleotide synthesis

TriLink BioTechnologies provides advanced CRISPR tools and oligonucleotides for genome editing and synthetic biology. Their platform supports rapid design and synthesis of guide RNAs and donor templates.

Sustainability & Growth Initiatives:

• Development of eco‑friendly purification processes
• Partnerships with academic research labs
• Investment in digital workflow automation

---

2️⃣ 9. ATDBio Ltd.

Headquarters: San Diego, California, USA
Key Offering: Synthetic oligonucleotides, gene synthesis, vaccine development

ATDBio Ltd. offers custom oligonucleotide synthesis and gene assembly services for research and therapeutic development. Their rapid synthesis pipelines support early‑stage drug discovery.

Sustainability & Growth Initiatives:

• Automated synthesis to reduce solvent use
• Collaboration with vaccine developers for mRNA platforms
• Implementation of waste‑to‑energy programs

---

1️⃣ 10. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany (US headquarters in Burlington, MA)
Key Offering: Commercial oligonucleotides, reagents, analytical kits

Sigma‑Aldrich, part of Merck KGaA, supplies a broad range of oligonucleotides for research, diagnostics, and therapeutics. Their extensive product catalog supports high‑throughput screening and assay development.

Sustainability & Growth Initiatives:

• Green chemistry in synthesis and purification
• Partnerships with pharma for therapeutic oligo pipelines
• Investment in digital supply chain transparency

---

Download FREE Sample Report: United States Oligonucleotide Market – View in Detailed Research Report

Get Full Report Here: United States Oligonucleotide Market – View in Detailed Research Report

🌍 Outlook: The Future of Oligonucleotide Innovation in the United States

The U.S. oligonucleotide market is set to accelerate as gene therapy, CRISPR, and vaccine technologies mature. Companies are investing heavily in automated synthesis, chemical modification, and platform integration to meet the growing demand for precision therapeutics and diagnostics.

📈 Key Trends Shaping the Market:

• Rapid expansion of CRISPR‑based therapeutics and diagnostics
• Growth of mRNA vaccine platforms and oligo‑based vaccine research
• Increased adoption of modified oligonucleotides for improved stability
• Digitalization of synthesis and supply chain management
• Strategic partnerships between biotech firms and large manufacturers

For detailed insights, download the full report and explore the comprehensive data, forecasts, and strategic recommendations.